Regional differences in hospital admissions for ST-elevation and non-ST-elevation myocardial infarctions during the Coronavirus disease-19 (COVID-19) pandemic in Austria
verfasst von:
Daniel Kiblboeck, Joerg Kellermair, Peter Siostrzonek, Clemens Steinwender
The first patients with Coronavirus disease-19 (COVID-19) were reported in Wuhan, China at the end of 2019 [1]. In February 2020, Lombardy and Veneto in northern Italy reported a dramatic increase of COVID-19 cases and became epicenters of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) outbreak in Europe [2]. On 25 February the first two cases of COVID-19 in Austria were confirmed in the neighboring region of Tyrol. In March, SARS-CoV‑2 infections spread over Austria with the highest incidences in West Austria (Tyrol, Vorarlberg, Salzburg) (Fig. 1a). The Austrian government declared an emergency lockdown with a stay at home order on 16 March. The whole state of Tyrol and some regions of Salzburg were quarantined.
Fig. 1
a COVID-19 incidence per 100,000 inhabitants in different states of Austria [6]. b Decrease of ACS (STEMI and NSTEMI) during COVID-19 pandemic in different states of Austria (calendar week 10 to 13). c Decrease of STEMI and NSTEMI in West (Tyrol, Vorarlberg, Salzburg) vs. East Austria (Upper Austria, Lower Austria, Styria, Vienna, Burgenland, Carinthia) in calendar weeks 10 and 11 before vs. weeks 12 and 13 after the lockdown. ACS acute coronary syndrome, COVID-19 Coronavirus disease-19, STEMI ST-elevation myocardial infarction, NSTEMI non-ST-elevation myocardial infarction
Regional differences in hospital admissions for ST-elevation and non-ST-elevation myocardial infarctions during the Coronavirus disease-19 (COVID-19) pandemic in Austria
verfasst von
Daniel Kiblboeck Joerg Kellermair Peter Siostrzonek Clemens Steinwender
